The Harvard-MIT Division of Health Sciences and Technology (HST) proposes to continue its successful training program in Bioinformatics and Integrative Genomics (BIG). This program addresses the growing gap between the ability to generate copious amounts genomic data and the ability to systematically and efficiently make sense of all this data. This program seeks to train competent, multidisciplinary researchers who are capable of both integrating the technologies into their experimental investigations and synthesizing the resulting datasets into coherent knowledge frameworks and mathematical models for formulating and resolving fundamental questions in biology and medicine. The BIG training program draws on three significant strengths of the local academic environment: the breadth of talented investigators at Harvard, MIT, and affiliated hospitals, the rich variety of quantitatively oriented courses in advanced genomics-bioinformatics offered at Harvard and MIT, and the template of HST's Medical Engineering and Medical Physics (MEMP) PhD program. As new track within MEMP, the BIG pre-doctoral program provides training in biomedical sciences and pathophysiology, as well as a formal introduction to clinical medicine. This proposal includes two main elements: the continuation of the predoctoral BIG training program established in 2001 and full institutionalization of the highly successful Summer Institute in Bioinformatics piloted in 2005. The Summer Institute is a key element of the plan to attract talented undergraduates, particularly women and underrepresented minorities, to the emerging field of genomics. Relevance: Perhaps the most important short-to-midterm translational aspect of bioinformatics and genomics is the ability to identify populations at risk for a variety of gene-by-environment interacting diseases. This includes morbid obesity and its frequent sequelae such as diabetes mellitus. This population-based risk stratification is an important first step in focusing primary prevention efforts as the most cost-effective way to lower the national disease burden. Given the significant representation of BIG faculty engaged in precisely this area of population-based risk stratification, and the large proportion of BIG students working with them, this aspect of public health and primary prevention is particularly well addressed by the training program.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HG002295-08
Application #
7921695
Study Section
Special Emphasis Panel (ZHG1-HGR-P (M2))
Program Officer
Graham, Bettie
Project Start
2000-07-01
Project End
2013-08-31
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
8
Fiscal Year
2010
Total Cost
$738,670
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Conway, Jake R; Kofman, Eric; Mo, Shirley S et al. (2018) Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine. Genome Med 10:93
Fang, Chao; Zhong, Huanzi; Lin, Yuxiang et al. (2018) Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing. Gigascience 7:1-8
Wala, Jeremiah A; Bandopadhayay, Pratiti; Greenwald, Noah F et al. (2018) SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res 28:581-591
Lodato, Michael A; Rodin, Rachel E; Bohrson, Craig L et al. (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359:555-559
Brown, Adam S; Patel, Chirag J (2018) A review of validation strategies for computational drug repositioning. Brief Bioinform 19:174-177
Brown, Adam S; Rasooly, Danielle; Patel, Chirag J (2018) Leveraging Population-Based Clinical Quantitative Phenotyping for Drug Repositioning. CPT Pharmacometrics Syst Pharmacol 7:124-129
Sagers, Jessica E; Brown, Adam S; Vasilijic, Sasa et al. (2018) Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma. Sci Rep 8:5437
Luber, Jacob M; Tierney, Braden T; Cofer, Evan M et al. (2018) Aether: leveraging linear programming for optimal cloud computing in genomics. Bioinformatics 34:1565-1567
Villani, Alexandra-ChloƩ; Satija, Rahul; Reynolds, Gary et al. (2017) Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356:
Kosmicki, Jack A; Samocha, Kaitlin E; Howrigan, Daniel P et al. (2017) Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet 49:504-510

Showing the most recent 10 out of 79 publications